Product image of Granisetron Hameln Pharma (Granisetron Hydrochloride) supplied by GNH India

Granisetron Hameln Pharma

Active Ingredient:
Granisetron Hydrochloride
Origin:
EU

Granisetron Hameln Pharma (Granisetron Hydrochloride)

Granisetron Hameln Pharma is an intravenous formulation of granisetron hydrochloride, a selective 5‑HT3 receptor antagonist used as an antiemetic. It is supplied as a prescription‑only product in the European market. The preparation is intended for administration by health‑care professionals to help prevent nausea and vomiting associated with chemotherapy or surgery. The medication is packaged in sterile vials and must be diluted according to the prescribing information before intravenous infusion.

Manufacturer / TM Owner

Hameln Pharma Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Granisetron Hameln Pharma is indicated for the prevention of nausea and vomiting in specific clinical settings.

  • Prevention of chemotherapy‑induced nausea and vomiting (CINV) in adult patients receiving highly or moderately emetogenic regimens.
  • Prevention of postoperative nausea and vomiting (PONV) following general anesthesia.
  • Adjunct therapy for radiation‑induced nausea when combined with other antiemetics.
  • Use in patients who have not responded adequately to other 5‑HT3 antagonists.

Side Effects

The safety profile of Granisetron Hameln Pharma reflects the typical effects observed with 5‑HT3 receptor antagonists.

Common

  • Headache
  • Constipation
  • Dizziness or light‑headedness
  • Fatigue or mild weakness
  • Injection‑site pain or erythema
  • Altered taste perception

Serious

  • Severe allergic reactions (anaphylaxis, angioedema)
  • QT interval prolongation and associated arrhythmias
  • Cardiac arrhythmias such as torsades de pointes
  • Serotonin syndrome when combined with other serotonergic agents
  • Marked hypotension or cardiovascular collapse

Precautions & Warnings

When prescribing Granisetron Hameln Pharma, clinicians should consider several precautionary measures to ensure safe use.

  • Assess cardiac history, especially prolonged QT interval; a baseline ECG may be recommended.
  • Use cautiously in patients with electrolyte abnormalities such as hypokalemia or hypomagnesemia.
  • Evaluate for known hypersensitivity to granisetron or other 5‑HT3 antagonists.
  • Adjust therapy in patients with hepatic impairment; monitor for increased exposure.
  • Consider potential effects on fetal development; use only if benefits outweigh risks during pregnancy.
  • Monitor for signs of constipation or bowel obstruction in at‑risk patients.

Avoid Interactions

Granisetron Hameln Pharma may interact with other medications that affect cardiac conduction or serotonin pathways.

Avoid

  • Concurrent use with other QT‑prolonging agents (e.g., certain antiarrhythmics, macrolide antibiotics).
  • Co‑administration with other 5‑HT3 antagonists or serotonergic drugs (e.g., ondansetron, tramadol) may increase risk of serotonin syndrome.

Use with caution

  • Combination with CYP3A4 inhibitors or inducers may alter granisetron plasma levels.
  • Use alongside drugs that cause electrolyte shifts (diuretics) may exacerbate QT risk.
  • Concomitant use with anesthetic agents that depress respiration should be monitored.

Frequently Asked Questions

Granisetron Hameln Pharma works by selectively blocking peripheral and central 5‑HT3 receptors, which prevents serotonin‑mediated signals that trigger nausea and vomiting.

It is commonly used to prevent nausea and vomiting caused by chemotherapy, postoperative recovery after general anesthesia, and sometimes radiation therapy when combined with other antiemetics.

The product is supplied for intravenous injection and must be diluted according to the prescribing information before infusion by a qualified health‑care professional.

Use in children should follow local regulatory guidance and be based on clinical judgment; dosing and safety data are primarily established in adult populations.

Common adverse effects include headache, constipation, dizziness, fatigue, injection‑site discomfort, and altered taste perception.

Serious reactions such as severe allergic responses, QT prolongation leading to arrhythmias, serotonin syndrome, or sudden hypotension should be evaluated urgently.

An ECG is advisable for patients with a history of cardiac disease or known QT interval abnormalities to assess the risk of prolongation.

The medication should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, and after consulting a health‑care provider.

Drugs that also prolong the QT interval (e.g., certain antiarrhythmics, macrolide antibiotics) and other serotonergic agents should be avoided to reduce the risk of cardiac events and serotonin syndrome.

Hepatic impairment can increase granisetron exposure; dose adjustments or increased monitoring may be necessary in patients with moderate to severe liver dysfunction.

Yes, it can be used as part of a multimodal antiemetic regimen, but clinicians should avoid combining it with other 5‑HT3 antagonists to prevent overlapping toxicity.

Monitoring may include assessment of cardiac rhythm (ECG), electrolyte levels, signs of constipation, and observation for any allergic reactions during and after infusion.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Granisetron Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT